Company Filing History:
Years Active: 2025
Title: Ying Wang - Innovator in Pharmaceutical Aerosol Formulations
Introduction
Ying Wang is a notable inventor based in Rancho Cucamonga, CA (US). He has made significant contributions to the field of pharmaceutical aerosol formulations, particularly focusing on environmentally friendly solutions. His innovative work has led to the development of a unique formulation that enhances the delivery of medication to patients.
Latest Patents
Ying Wang holds a patent for an "Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent." This formulation includes pre-micronized albuterol sulfate and utilizes a high amount of green propellant trans-1,3,3,3-tetrafluoropropene (HFO-1234ze(E)). The formulation is designed to be co-solvent-free, meaning it does not contain ethanol, glycerol, or propylene glycol. This innovative approach provides highly efficient delivery of albuterol particles through a metered dose inhaler (MDI), ensuring high efficacy, improved safety, and a low global warming potential (GWP).
Career Highlights
Ying Wang is currently employed at Amphastar Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical formulations. His work is pivotal in developing safer and more effective inhalation therapies for patients.
Collaborations
Ying Wang collaborates with esteemed colleagues such as Jack Yongfeng Zhang and Ray Lameng Lei. Their combined expertise contributes to the innovative projects at Amphastar Pharmaceuticals, Inc.
Conclusion
Ying Wang's contributions to pharmaceutical aerosol formulations exemplify the intersection of innovation and environmental responsibility. His work not only enhances patient care but also addresses global environmental concerns.